Oppenheimer Upgrades Sarepta Therapeutics (SRPT) to Outperform
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $18.22 --0%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 6
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 6
Join SI Premium – FREE
Oppenheimer analyst Hartaj Singh upgraded Sarepta Therapeutics (NASDAQ: SRPT) from Perform to Outperform with a price target of $180.00.
For an analyst ratings summary and ratings history on Sarepta Therapeutics click here. For more ratings news on Sarepta Therapeutics click here.
Shares of Sarepta Therapeutics closed at $131.70 yesterday.
You May Also Be Interested In
- ICICI Securities Upgrades Multi Commodity Exchange of India Ltd (MCX:IN) to Add (2)
- Citi Upgrades Cosmax Inc (192820:KS) to Buy
- Sarepta Therapeutics (SRPT) PT Lowered to $35 at Oppenheimer
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
